BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ginsberg G, Guyton K, Johns D, Schimek J, Angle K, Sonawane B. Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment. Crit Rev Toxicol 2010;40:575-619. [PMID: 20662711 DOI: 10.3109/10408441003742895] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Wei Z, Han D, Zhang C, Wang S, Liu J, Chao F, Song Z, Chen G. Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer. Front Oncol 2022;12:893424. [DOI: 10.3389/fonc.2022.893424] [Reference Citation Analysis]
2 Pernaute-Lau L, Camara M, Nóbrega de Sousa T, Morris U, Ferreira MU, Gil JP. An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria. Expert Opin Drug Metab Toxicol 2022;18:39-59. [PMID: 35285373 DOI: 10.1080/17425255.2022.2049235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kumar R, Rani R, Narang SK, Rai S, Hajam YA. Hepatotoxicity: Its physiological pathways and control measures using phyto-polyphenols. Phytomedicine 2021. [DOI: 10.1016/b978-0-12-824109-7.00007-8] [Reference Citation Analysis]
4 Lv X, Xia Y, Finel M, Wu J, Ge G, Yang L. Recent progress and challenges in screening and characterization of UGT1A1 inhibitors. Acta Pharm Sin B 2019;9:258-78. [PMID: 30972276 DOI: 10.1016/j.apsb.2018.09.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
5 Lv X, Zhang JB, Hou J, Dou TY, Ge GB, Hu WZ, Yang L. Chemical Probes for Human UDP-Glucuronosyltransferases: A Comprehensive Review. Biotechnol J 2019;14:e1800002. [PMID: 30192065 DOI: 10.1002/biot.201800002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
6 Ho V, Peacock S, Massey TE, Godschalk RW, van Schooten FJ, Ashbury JE, Vanner SJ, King WD. Bulky DNA adduct levels in normal-appearing colon mucosa, and the prevalence of colorectal adenomas. Biomarkers 2018;23:735-41. [PMID: 29871536 DOI: 10.1080/1354750X.2018.1485055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Lv X, Zhang J, Wang X, Hu W, Shi Y, Liu S, Hao D, Zhang W, Ge G, Hou J, Yang L. Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases. Chemico-Biological Interactions 2018;284:48-55. [DOI: 10.1016/j.cbi.2018.02.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
8 Yang G, Ge S, Singh R, Basu S, Shatzer K, Zen M, Liu J, Tu Y, Zhang C, Wei J, Shi J, Zhu L, Liu Z, Wang Y, Gao S, Hu M. Glucuronidation: driving factors and their impact on glucuronide disposition. Drug Metab Rev 2017;49:105-38. [PMID: 28266877 DOI: 10.1080/03602532.2017.1293682] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
9 Wang M, Yang G, He Y, Xu B, Zeng M, Ge S, Yin T, Gao S, Hu M. Establishment and use of new MDCK II cells overexpressing both UGT1A1 and MRP2 to characterize flavonoid metabolism via the glucuronidation pathway. Mol Nutr Food Res 2016;60:1967-83. [PMID: 26833852 DOI: 10.1002/mnfr.201500321] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
10 Hodges RE, Minich DM. Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application. J Nutr Metab 2015;2015:760689. [PMID: 26167297 DOI: 10.1155/2015/760689] [Cited by in Crossref: 94] [Cited by in F6Publishing: 100] [Article Influence: 11.8] [Reference Citation Analysis]
11 Pavlović NM. Balkan endemic nephropathy-current status and future perspectives. Clin Kidney J 2013;6:257-65. [PMID: 26064484 DOI: 10.1093/ckj/sft049] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
12 Ho V, Peacock S, Massey TE, Godschalk RW, van Schooten FJ, Chen J, King WD. Gene-diet interactions in exposure to heterocyclic aromatic amines and bulky DNA adduct levels in blood leukocytes. Environ Mol Mutagen 2015;56:609-20. [PMID: 26010176 DOI: 10.1002/em.21950] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
13 Lash LH, Chiu WA, Guyton KZ, Rusyn I. Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity. Mutat Res Rev Mutat Res 2014;762:22-36. [PMID: 25484616 DOI: 10.1016/j.mrrev.2014.04.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 8.3] [Reference Citation Analysis]
14 Liu K, Ye J, Huang Y, Qin C, Li P, Liu B, Li J, Yin C. Quantitative analysis of the association between sulfotransferase isoform 1A1 polymorphism and risk of urothelial carcinoma. Mol Clin Oncol 2015;3:93-100. [PMID: 25469277 DOI: 10.3892/mco.2014.406] [Reference Citation Analysis]
15 Cerda A, Hirata MH, Hirata RDC. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations. Drug Metabolism and Drug Interactions 2014;29. [DOI: 10.1515/dmdi-2013-0067] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
16 Zhang J, Zhang X. Environment, Heredity, and Epidemiology. Asia Pac J Public Health 2013;25:4S-5S. [DOI: 10.1177/1010539513499108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Martin OV, Martin S, Kortenkamp A. Dispelling urban myths about default uncertainty factors in chemical risk assessment--sufficient protection against mixture effects? Environ Health 2013;12:53. [PMID: 23816180 DOI: 10.1186/1476-069X-12-53] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
18 Wei Y, Wu B, Jiang W, Yin T, Jia X, Basu S, Yang G, Hu M. Revolving door action of breast cancer resistance protein (BCRP) facilitates or controls the efflux of flavone glucuronides from UGT1A9-overexpressing HeLa cells. Mol Pharm 2013;10:1736-50. [PMID: 23402418 DOI: 10.1021/mp300562q] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
19 Lin ZN, Lin YC, Zhang X, Kadlubar S, Tuo J, Green B, Deng H, Ning B. Differential promoter activities of functional haplotypes in the 5'-flanking region of human sulfotransferase 1A1. J Biochem Mol Toxicol 2012;26:422-8. [PMID: 23080433 DOI: 10.1002/jbt.21437] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
20 Nousome D, Lupo PJ, Okcu MF, Scheurer ME. Maternal and offspring xenobiotic metabolism haplotypes and the risk of childhood acute lymphoblastic leukemia. Leuk Res 2013;37:531-5. [PMID: 23433810 DOI: 10.1016/j.leukres.2013.01.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
21 Chung C, Huang C, Pu Y, Shiue H, Su C, Hsueh Y. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype. Toxicology and Applied Pharmacology 2013;266:254-9. [DOI: 10.1016/j.taap.2012.11.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
22 Zeise L, Bois FY, Chiu WA, Hattis D, Rusyn I, Guyton KZ. Addressing human variability in next-generation human health risk assessments of environmental chemicals. Environ Health Perspect 2013;121:23-31. [PMID: 23086705 DOI: 10.1289/ehp.1205687] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 8.1] [Reference Citation Analysis]
23 Rietjens SJ, Hondebrink L, Westerink RH, Meulenbelt J. Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions. Crit Rev Toxicol 2012;42:854-76. [PMID: 23030234 DOI: 10.3109/10408444.2012.725029] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
24 Tung MC, Wang YH, Yeh SD, Wu CC, Chen KC, Huang ZM, Huang MT, Chiou HY. Combined effects of GSTO1 and SULT1A1 polymorphisms and cigarette smoking on urothelial carcinoma risk in a Taiwanese population. J Formos Med Assoc 2014;113:640-7. [PMID: 25103078 DOI: 10.1016/j.jfma.2012.08.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
25 Liu C, Fan D, Shi Y, Zhou Q. A glimpse of enzymology within the idea of systems. Sci China Life Sci 2012;55:826-833. [DOI: 10.1007/s11427-012-4371-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Lacko M, Voogd AC, Roelofs HMJ, te Morsche RHM, Ophuis MBO, Peters WHM, Manni JJ. Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk. Head Neck 2013;35:858-67. [DOI: 10.1002/hed.23054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
27 Variability, Uncertainty, and Sensitivity Analysis. Physiologically-Based Pharmacokinetic (PBPK) Modeling and Simulations 2012. [DOI: 10.1002/9781118140291.ch8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
28 Sahin O, Arikan S, Oltulu YM, Coskunpinar E, Eren A, Cacina C, Guler E, Yaylim I. Investigation of a possible relationship between EPHX1 gene polymorphisms and colorectal cancer in Turkish society. Genet Test Mol Biomarkers 2012;16:423-8. [PMID: 22352736 DOI: 10.1089/gtmb.2011.0223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
29 Boddupalli S, Mein JR, Lakkanna S, James DR. Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins a, C, and e. Front Genet 2012;3:7. [PMID: 22303412 DOI: 10.3389/fgene.2012.00007] [Cited by in Crossref: 63] [Cited by in F6Publishing: 71] [Article Influence: 5.7] [Reference Citation Analysis]
30 Shen K, Wu C, Wang Y, Huang SK, Hwang TIS, Yeh C, Juang G. <i>Sulfotransferase</i> 1A1 G638A polymorphism, cigarette smoking and bladder cancer risk in Taiwan. ABB 2012;03:186-190. [DOI: 10.4236/abb.2012.33027] [Reference Citation Analysis]
31 Woodruff TJ, Burke TA, Zeise L. The need for better public health decisions on chemicals released into our environment. Health Aff (Millwood) 2011;30:957-67. [PMID: 21555480 DOI: 10.1377/hlthaff.2011.0194] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
32 Lindemer BJ, Bongard RD, Hoffmann R, Baumgardt S, Gonzalez FJ, Merker MP. Genetic evidence for NAD(P)H:quinone oxidoreductase 1-catalyzed quinone reduction on passage through the mouse pulmonary circulation. Am J Physiol Lung Cell Mol Physiol 2011;300:L773-80. [PMID: 21296895 DOI: 10.1152/ajplung.00394.2010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Wilson VS, Keshava N, Hester S, Segal D, Chiu W, Thompson CM, Euling SY. Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment. Toxicol Appl Pharmacol 2013;271:299-308. [PMID: 21295051 DOI: 10.1016/j.taap.2011.01.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
34 Bayrak A, Bayrak T, Demirpençe E, Kılınç K. Differential hydrolysis of homocysteine thiolactone by purified human serum (192)Q and (192)R PON1 isoenzymes. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:49-55. [PMID: 21123122 DOI: 10.1016/j.jchromb.2010.11.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]